Bioray Biotech Co (ROCO:7561) Shares Outstanding (Basic Average): 29.6 Mil (As of Dec. 2025)


ROCO:7561 Bioray Biotech Co Ltd ROCO:7561
83 GF Score
Price NT$18.65
GF Value NT$29.46
Valuation Significantly Undervalued
View Full Analysis

What is Bioray Biotech Co Shares Outstanding (Basic Average)?

Bioray Biotech Co ROCO:7561 -1.84% 83 Shares Outstanding (Basic Average) is 29.6 Mil as of Dec. 2025. GuruFocus rates ROCO:7561 with a GF Score™ of 83/100 and a GF Value™ of NT$29.46 (Significantly Undervalued).

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Bioray Biotech Co's average basic shares outstanding for the quarter that ended in Dec. 2025 was 29.6 Mil.


Bioray Biotech Co  (ROCO:7561) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Bioray Biotech Co Shares Outstanding (Basic Average) Related Terms


Bioray Biotech Co Shares Outstanding (Basic Average) Historical Data

* Premium members only.

The historical data trend for Bioray Biotech Co's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioray Biotech Co Shares Outstanding (Basic Average) Chart

Bioray Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (Basic Average)
Get a 7-Day Free Trial Premium Member Only 26.77 28.02 30.09 29.83 29.59

Bioray Biotech Co Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.09 30.07 29.60 29.59 29.59
ROCO:7561
83GF Score
Bioray Biotech Co Ltd ROCO:7561
Shares Outstanding (Basic Average) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioray Biotech Co Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Basic Average) of 29.6 Mil mean?
Bioray Biotech Co (ROCO:7561) has a Shares Outstanding (Basic Average) of 29.6 Mil as of Dec. 2025. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Bioray Biotech Co and its competitors.
Is Bioray Biotech Co's Shares Outstanding (Basic Average) too high?
Bioray Biotech Co's current Shares Outstanding (Basic Average) is 29.6 Mil. Overall, Bioray Biotech Co has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioray Biotech Co's Shares Outstanding (Basic Average) compare to ZTS?
Bioray Biotech Co's Shares Outstanding (Basic Average) of 29.6 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Basic Average) for a Drug Manufacturers company?
A good Shares Outstanding (Basic Average) depends on the Drug Manufacturers industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Basic Average) mean?
A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Bioray Biotech Co and its competitors. Bioray Biotech Co's current Shares Outstanding (Basic Average) is 29.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioray Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Bioray Biotech Co (ROCO:7561) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$29.46, compared to a current price of NT$18.65 — trading 36.7% below its estimated fair value. The current Shares Outstanding (Basic Average) is 29.6 Mil. Bioray Biotech Co's overall GF Score™ is 83/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Basic Average) calculated?
Shares Outstanding (Basic Average) is calculated from a company's financial statements. For Bioray Biotech Co (ROCO:7561), the current Shares Outstanding (Basic Average) is 29.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioray Biotech Co (ROCO:7561) Overvalued in 2026?

Based on GuruFocus' analysis, Bioray Biotech Co stock appears to be undervalued. The current stock price of NT$18.65 is trading 36.7% below its estimated GF Value™ of NT$29.46. GuruFocus considers Bioray Biotech Co to be Significantly Undervalued.

Key valuation signals for ROCO:7561:

  • Shares Outstanding (Basic Average): 29.6 Mil
  • GF Value™: NT$29.46 vs. price of NT$18.65 (36.7% below fair value)
  • GF Score™: 83/100

No single metric tells the full story. See the ROCO:7561 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bioray Biotech Co Business Description

Address No. 1, Dali 2nd Road, Southern Science Park, Shanhua District, Tainan, TWN, 90846
Bioray Biotech Co Ltd is engaged in the development and manufacturing of biological agents, including functional probiotics, medicinal fungi, and immune cell preparations.
83GF Score

Get the complete analysis for ROCO:7561

Shares Outstanding (Basic Average) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.65
Price
NT$29.46
GF Value